IL129171A - An oral preparation containing at least one active pharmaceutical ingredient in a matrix capable of swelling in a liquid medium - Google Patents

An oral preparation containing at least one active pharmaceutical ingredient in a matrix capable of swelling in a liquid medium

Info

Publication number
IL129171A
IL129171A IL12917197A IL12917197A IL129171A IL 129171 A IL129171 A IL 129171A IL 12917197 A IL12917197 A IL 12917197A IL 12917197 A IL12917197 A IL 12917197A IL 129171 A IL129171 A IL 129171A
Authority
IL
Israel
Prior art keywords
matrix
layer
swellable
aqueous medium
swelling
Prior art date
Application number
IL12917197A
Other languages
English (en)
Hebrew (he)
Other versions
IL129171A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL129171A0 publication Critical patent/IL129171A0/xx
Publication of IL129171A publication Critical patent/IL129171A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12917197A 1996-09-28 1997-08-29 An oral preparation containing at least one active pharmaceutical ingredient in a matrix capable of swelling in a liquid medium IL129171A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
PCT/EP1997/004717 WO1998013028A1 (de) 1996-09-28 1997-08-29 Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff

Publications (2)

Publication Number Publication Date
IL129171A0 IL129171A0 (en) 2000-02-17
IL129171A true IL129171A (en) 2001-11-25

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12917197A IL129171A (en) 1996-09-28 1997-08-29 An oral preparation containing at least one active pharmaceutical ingredient in a matrix capable of swelling in a liquid medium

Country Status (23)

Country Link
US (1) US6238698B1 (pt)
EP (1) EP0946150B1 (pt)
JP (1) JP2001504807A (pt)
KR (1) KR100493139B1 (pt)
CN (1) CN1139378C (pt)
AT (1) ATE213933T1 (pt)
AU (1) AU724802B2 (pt)
CA (1) CA2260845C (pt)
CZ (1) CZ291258B6 (pt)
DE (2) DE19640062B4 (pt)
DK (1) DK0946150T3 (pt)
ES (1) ES2174296T3 (pt)
HU (1) HU227865B1 (pt)
IL (1) IL129171A (pt)
MY (1) MY130959A (pt)
NO (1) NO991477L (pt)
NZ (1) NZ333401A (pt)
PL (1) PL188392B1 (pt)
PT (1) PT946150E (pt)
SI (1) SI0946150T1 (pt)
SK (1) SK282709B6 (pt)
WO (1) WO1998013028A1 (pt)
ZA (1) ZA978625B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US8226967B2 (en) 2008-11-27 2012-07-24 Basf Se Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
WO1994002121A1 (en) * 1992-07-24 1994-02-03 Labopharm Inc. Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
JP2001504807A (ja) 2001-04-10
WO1998013028A1 (de) 1998-04-02
SI0946150T1 (en) 2002-08-31
HUP9903115A2 (hu) 2000-02-28
EP0946150B1 (de) 2002-03-06
HUP9903115A3 (en) 2000-03-28
DE19640062B4 (de) 2006-04-27
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
DK0946150T3 (da) 2002-06-24
CA2260845A1 (en) 1998-04-02
PL332577A1 (en) 1999-09-27
AU724802B2 (en) 2000-09-28
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
CN1231600A (zh) 1999-10-13
SK282709B6 (sk) 2002-11-06
ATE213933T1 (de) 2002-03-15
NO991477L (no) 1999-03-26
PT946150E (pt) 2002-08-30
CA2260845C (en) 2005-11-22
CZ101399A3 (cs) 1999-07-14
CN1139378C (zh) 2004-02-25
PL188392B1 (pl) 2005-01-31
CZ291258B6 (cs) 2003-01-15
NZ333401A (en) 1999-10-28
IL129171A0 (en) 2000-02-17
DE19640062A1 (de) 1998-04-09
EP0946150A1 (de) 1999-10-06
AU4619397A (en) 1998-04-17
KR100493139B1 (ko) 2005-06-02
ZA978625B (en) 1998-03-26
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
KR20010029533A (ko) 2001-04-06
MY130959A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
EP1138320B1 (de) Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
RU2453306C2 (ru) Твердые оральные дозируемые формы на основе вальсартана
RU2122413C1 (ru) Форма фармацевтического дозирования, обеспечивающая продолжительное выделение активного ингредиента
JPH01250314A (ja) 徐放性製剤
IE60661B1 (en) Nitrofurantoin dosage form
AU6279994A (en) Cross-linked amylose as a binder/disintegrant in tablets
JP2002275053A (ja) 医薬錠剤及びその製造のための方法
Saeio et al. Factors influencing drug dissolution characteristic from hydrophilic polymer matrix tablet
HU193731B (en) Process for preparing galenic form comprising polycaprolactone-based, neutral matrix suitable for the oral dosage of medicines
IL129171A (en) An oral preparation containing at least one active pharmaceutical ingredient in a matrix capable of swelling in a liquid medium
HU221590B (hu) Béta-fenil-propiofenon-származékokat tartalmazó retard mikrotabletták
EP0524395B1 (en) Sustained release compositions containing bile acids
Dalavi et al. Gastroretentive drug delivery system of an antiretroviral agent
Uddin et al. In vitro release kinetics study of ranolazine from swellable hydrophilic matrix tablets
EP0814772B1 (en) Pectin pharmaceutical compositions
WO2002102415A1 (en) Gastric floating system
AU2019254487B2 (en) Sustained release pyridostigmine compositions
EP3556357B1 (en) Sustained release pyridostigmine compositions
DE60319982T2 (de) Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat
Chakraborty et al. Development of extended release divalproex sodium tablets containing hypdrophobic and hydrophilic matrix
Phaechamud Effect of particle size of chitosan on drug release from layered matrix system comprising chitosan and xanthan gum
AU5508799A (en) Compressed compositions comprising clarified xanthan gum
MXPA99011232A (en) Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees